LEGN

33.93

3.22% -1.13

After Hours: 33.93

Legend Biotech Corp Adr (LEGN)

Overview News Price History Option Chain Why LEGN Down? Discussions Forecast

Legend Biotech Corp Adr stock is traded at $33.93, with a volume of 1.27M. It is down -3.22% in the last 24 hours and down -3.08% over the past month.

Previous Close:

$35.06

Open:

$33.98

24h Volume:

1.27M

Relative Volume:

1.12

Market Cap:

$6.50B

Revenue:

$520.18M

Net Income/Loss:

$-348.13M

P/E Ratio:

-17.67

EPS:

-1.92

Net Cash Flow:

$-176.18M

1W Performance:

-6.61%

1M Performance:

-3.08%

6M Performance:

-30.37%

1Y Performance:

-39.51%

1-Day Range:

$32.85

$34.41

1-Week Range:

$32.85

$36.33

52-Week Range:

$30.17

$60.87

Legend Biotech Corp Adr Stock (LEGN) Company Profile

Name

Legend Biotech Corp Adr

Sector

Healthcare (1164)

Industry

Biotechnology (681)

Phone

Address

Employee

Twitter

@LegendBiotech

Next Earnings Date

2025-03-11

Latest SEC Filings

LEGN's Discussions on Twitter

Compare LEGN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LEGN Legend Biotech Corp Adr	33.93	6.50B	520.18M	-348.13M	-176.18M	-1.92
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-08-24	Initiated	Redburn Atlantic	Buy
Jun-17-24	Initiated	Truist	Buy
May-24-24	Reiterated	H.C. Wainwright	Buy
May-23-24	Initiated	Deutsche Bank	Buy
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight
Mar-13-24	Initiated	Raymond James	Outperform
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy
May-25-23	Initiated	William Blair	Mkt Perform
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy
Mar-24-23	Initiated	RBC Capital Mkts	Outperform
Dec-06-22	Initiated	UBS	Buy
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Mar-15-22	Initiated	Barclays	Overweight
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-06-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-21-21	Initiated	Piper Sandler	Overweight
May-18-21	Initiated	BTIG Research	Buy
Jul-01-20	Initiated	JP Morgan	Overweight
Jul-01-20	Initiated	Jefferies	Buy
Jun-30-20	Initiated	Morgan Stanley	Overweight

View All

Legend Biotech Corp Adr Stock (LEGN) Latest News

Mar 17, 2025

Legend Biotech’s SWOT analysis: carvykti’s strong efficacy drives stock outlook - Investing.com

Mar 17, 2025

Mar 13, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares - Investing.com

Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares By Investing.com - Investing.com South Africa

Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target - Investing.com

Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target By Investing.com - Investing.com UK

Mar 12, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target - Investing.com India

Mar 12, 2025

Legend Biotech stock price target raised to $75 at H.C. Wainwright - Investing.com India

Mar 12, 2025

Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates By Investing.com - Investing.com South Africa

Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates - Investing.com India

Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth By Investing.com - Investing.com South Africa

Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth - Investing.com India

Mar 11, 2025

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - Yahoo

Mar 11, 2025

Feb 28, 2025

Legend Biotech CorpADR to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

Feb 13, 2025

Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 13, 2025

Feb 11, 2025

Market Momentum: Aptargroup Inc (ATR) Registers a 0.07 Increase, Closing at 143.28 - The Dwinnex

Feb 11, 2025

Feb 10, 2025